The world of cardio-oncology is evolving at an unprecedented pace, and the Global Cardio-Oncology Summit (GCOS) 2025 in Cape Town, South Africa, brought together the brightest minds to explore this exciting field. As Aaron Sverdlov, Professor and Director of Heart Failure at the University of Newcastle, Co-Director of the Newcastle Centre of Excellence in Cardio-Oncology at Hunter Medical Research Institute (HMRI), shares, the summit focused on five critical themes that are shaping the future of cancer-related cardiovascular care.
The 'Big 5' Themes in Cancer-Related Cardiovascular Care
- Baseline Risk Assessment: Identifying individuals at risk before cancer therapy begins is crucial. This helps in tailoring treatment plans and minimizing potential heart-related complications.
- Surveillance and Prevention: Monitoring patients for early signs of heart problems and implementing preventive measures is essential. This proactive approach can help avoid clinical issues and improve patient outcomes.
- Optimal Treatment: When cardiotoxicity or pre-existing cardiovascular disease is present, treatment decisions become more complex. Understanding the best course of action is vital for managing these conditions effectively.
- Survivorship: Long-term follow-up and managing late effects are essential for patients who have survived cancer. Lifestyle factors and support systems play a significant role in their overall well-being.
- Multidisciplinary Service Delivery: Organizing cardio-oncology services in real-world settings requires collaboration between various medical disciplines. This ensures that patients receive comprehensive care tailored to their unique needs.
Big Announcements and Recognitions
The summit also witnessed significant announcements and recognitions. The International Cardio-Oncology Society confirmed the next two stops for the Global Cardio-Oncology Summit: GCOS 2026 in Williamsburg, Virginia, USA, and GCOS 2027 in Tokyo, Japan. These events will further strengthen global collaboration and showcase the advancements in Asia-Pacific cardio-oncology.
One of the highlights of GCOS 2025 was the honor bestowed upon Teresa López Fernández with the International Cardio-Oncology Society Thomas Force Award. This prestigious recognition, named after Tom Force, acknowledges his groundbreaking work in setting the tone for rigorous, translational cardio-oncology. Teresa's contributions, including the ESC cardio-oncology guidance, cardiac imaging pathways, and building national-level cardio-oncology services in Spain, have been instrumental in shaping the field.
Practical Insights and Controversial Topics
The summit also featured practical talks and discussions on controversial topics. Michael Fradley, MD, presented a talk on managing thrombosis in cardio-oncology patients, highlighting the common challenges and the importance of multidisciplinary input. Joshua Mitchell, on the other hand, discussed the role of cardiac biomarkers in the diagnosis and prevention of cardiotoxicity, emphasizing the value of structured biomarker use and the importance of trending over one-off values.
Siva Tharshini Ramalingam's session on the importance of primary care in cardio-oncology was particularly insightful. It underscored the fact that for many cancer patients, the first person to notice symptoms like breathlessness, tachycardia, or odd ECG readings is often the general practitioner (GP), not the cardio-oncologist. This highlights the need for clear escalation protocols and shared protocols that can be adapted for regional and rural settings.
Looking Ahead
GCOS 2025 has set the stage for the future of cardio-oncology, with its focus on collaboration, innovation, and practical solutions. As Aaron Sverdlov concludes, the summit has brought together leaders from around the world to advance the field and improve outcomes for patients living with both cancer and cardiovascular disease. The next stops for the Global Cardio-Oncology Summit will further strengthen global collaboration and showcase the advancements in Asia-Pacific cardio-oncology.
As the field continues to evolve, it is essential to stay informed and engaged with the latest research and advancements. The Global Cardio-Oncology Summit serves as a vital platform for healthcare professionals worldwide to come together, share knowledge, and work towards improving outcomes for patients facing the unique challenges of cancer and cardiovascular disease.
